Are some orphan drugs for rare diseases too expensive? A study of purchase versus compounding costs

被引：8

作者：

Simoens S. ^{[1
]}

Cassiman D. ^{[2
]}

Picavet E. ^{[1
]}

Dooms M. ^{[3
]}

机构：

[1] Research Centre for Pharmaceutical Care and Pharmaco-economics, Katholieke Universiteit Leuven, 3000 Leuven, Onderwijs en Navorsing 2

[2] Department of Hepatology, University Hospital Leuven, Leuven

[3] Hospital Pharmacy, University Hospital Leuven, Leuven

来源：

Drugs & Therapy Perspectives | 2011年 / 27卷 / 10期

关键词：

Orphan Drug; Healthcare Payer; Orphan Designation; Belgian Hospital; Hospital Price;

D O I：

10.2165/11601640-000000000-00000

中图分类号：

学科分类号：

摘要：

Hospital purchase prices substantially exceed compounding production costs in Belgium for selected orphan drugs that had low costs of research and development and market access procedures. As a result, healthcare payers seem to be paying too much for these orphan drugs and there are arguments for price reductions. Pharmacies can consider compounding, rather than purchasing, these orphan drugs. © 2011 Adis Data Information BV. All rights reserved.

引用

页码：24 / 26

页数：2

共 50 条

[1] Rare diseases and expensive drugs
Katelaris, Constance H.
ASIA PACIFIC ALLERGY, 2014, 4 (02) : 73 - 74
[2] Rare diseases and orphan drugs
Aronson, JK
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (03) : 243 - 245
[3] Rare diseases and orphan drugs
Irena Melnikova
Nature Reviews Drug Discovery, 2012, 11 : 267 - 268
[4] Rare diseases and orphan drugs
Melnikova, Irena
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (04) : 267 - 268
[5] RARE DISEASES AND ORPHAN DRUGS
DAINA, E
LANCET, 1994, 343 (8912): : 1560 - 1561
[6] Orphan drugs and rare diseases
Schulze-Bonhage, Andreas
Stephani, Ulrich
ZEITSCHRIFT FUR EPILEPTOLOGIE, 2019, 32 (04): : 263 - 263
[7] Rare diseases and orphan drugs
Taruscio, Domenica
Capozzoli, Fiorentino
Frank, Claudio
ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2011, 47 (01): : 83 - 93
[8] Rare diseases and "orphan" drugs
Hillcoat, BL
MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (02) : 69 - 70
[9] Development of orphan drugs for rare diseases
Yoo, Han-Wook
CLINICAL AND EXPERIMENTAL PEDIATRICS, 2024, 67 (07) : 315 - 327
[10] Orphan drugs and rare diseases in Andorra
Gea, E.
Gil, E.
Barral, N.
Gonzalez, V.
Soler, A.
Avellanet, M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 963 - 963

← 1 2 3 4 5 →